Sharechat Logo

Tower trading ahead of 2008 in first four months

Tuesday 17th February 2009

Text too small?
Tower's trading in the first four months of the year is ahead of the year-earlier period, helped by a slide in interest rates, which has allowed the group to revalue policyholder liabilities.

"I the current very challenging economic climate the board is pleased with this performance," chairman Tony Gibbs told shareholders at their annual meeting today.

Tower lifted 2008 profit by 17% on earnings from health and life insurance, and raised its dividend to 8 cents from 6 cents. Gibbs said today that investors have endorsed the company's performance, with holders of more than 33% of eligible shares opting to take more stock in lieu of dividends.

"Provided our profit targets are met, it is the board's intention to continue paying an annual dividend after the end of each financial year," Gibbs said.

Shares of Tower rose 2% to $1.53. In the past three months the shares have gained 4%, outpacing the NZX 50 Index, which fell almost 2%.

The insurance and investment management company this month offered to sell as much as $100 million of five-year bonds paying 8.5% interest, taking advantage of investors' appetite for high yields as deposit rates fall.

Buyers for the initial $80 million of bonds were lined up before the offer opened on Monday. Proceeds will be used to repay maturing debt, provide working capital and upgrade Tower's computer systems.

By Jonathan Underhill



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Tower to return 'initial' $70M of capital from sale of life business
Tower shares fall to 2-month low as licensing requirements may weigh on capital returns
Tower's licensing talks with RBNZ may push up minimum solvency requirements
Tower names Hancock as new chief executive, replacing Flannagan
Tower posts first-half profit as asset sales reap gains of $51.4 mln
Fidelity Life acquires most of Tower's life insurance business
Flannagan to leave Tower after strategic review, asset sales
Tower FY profit jumps 67%, to return $120M to shareholders; shares jump
Tower sells medical insurance unit to nib for $102M
Stiassny joins Tower board as questions linger over strategy